系统性硬化症患者进行性纤维化间质性肺病的预测:来自CRDC队列研究的洞察
本研究纳入304例在6至24个月内完成至少三次肺功能检查的系统性硬化症相关间质性肺病(SSc-ILD)患者,构建了包含9个变量的进行性纤维化间质性肺病(PF-ILD)预测模型,内部验证一致性指数为0.874,乐观校正Brier评分为0.144,显示模型具有较好的准确性和稳定性。
要点
- 纳入304例SSc-ILD患者,其中PF-ILD组154例,无PF-ILD组150例。
- 预测模型包含9个变量:年龄≥50岁、高脂血症、吸烟史、弥漫性皮肤型SSc、关节炎、气短、血清IgA降低、抗Scl-70抗体阳性、使用环磷酰胺/霉酚酸酯。
- 使用环磷酰胺/霉酚酸酯与PF-ILD风险降低相关(HR 0.4267)。
核心结论
- 本研究建立了首个用于SSc-ILD患者PF-ILD的预测模型,内部验证显示模型具有较好的准确性和稳定性。
研究设计与样本
- 纳入304例在6至24个月内完成至少三次肺功能检查的SSc-ILD患者,收集基线数据,比较PF-ILD组与无PF-ILD组的差异。
- 采用最小绝对收缩和选择算子正则化回归及多变量Cox回归构建预测模型,以列线图和森林图呈现。
主要发现
- 304例患者中92.1%为女性,基线平均年龄46.7岁。
- 基于组间比较预选的28个变量,构建了包含9个变量的预测模型。
- 模型变量及对应HR:年龄≥50岁(HR 1.8221,p=0.001)、高脂血症(HR 4.0516,p<0.001)、吸烟史(HR 3.8130,p<0.001)、弥漫性皮肤型SSc(HR 1.9753,p<0.001)、关节炎(HR 2.0008,p<0.001)、气短(HR 2.0487,p=0.012)、血清IgA降低(HR 2.3900,p=0.002)、抗Scl-70抗体阳性(HR 1.9573,p=0.016)、使用环磷酰胺/霉酚酸酯(HR 0.4267,p<0.001)。
- 增强bootstrap重采样调整后的一致性指数为0.874,内部验证中乐观校正Brier评分为0.144。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aims to establish a reliable prediction model of progressive fibrosing interstitial lung disease (PF-ILD) in patients with systemic sclerosis (SSc)-ILD, to achieve early risk stratification and to help better in preventing disease progression. METHODS: 304 SSc-ILD patients with no less than three pulmonary function tests within 6-24 months were included. We collected data at baseline and compared differences between SSc patients with and without PF-ILD. Least absolute shrinkage and selection operator regularisation regression and multivariable Cox regression were used to construct the prediction model, which were presented as nomogram and forest plot. RESULTS: Among the 304 patients with SSc-ILD included, 92.1% were women, with a baseline average age of 46.7 years. Based on the 28 variables preselected by comparison between SSc patients without PF-ILD group (n=150) and patients with SSc PF-ILD group (n=154), a 9-variable prediction model was constructed, including age≥50 years (HR 1.8221, p=0.001), hyperlipidemia (HR 4.0516, p<0.001), smoking history (HR 3.8130, p<0.001), diffused cutaneous SSc subtype (HR 1.9753, p<0.001), arthritis (HR 2.0008, p<0.001), shortness of breath (HR 2.0487, p=0.012), decreased serum immunoglobulin A level (HR 2.3900, p=0.002), positive anti-Scl-70 antibody (HR 1.9573, p=0.016) and usage of cyclophosphamide/mycophenolate mofetil (HR 0.4267, p<0.001). The concordance index after enhanced bootstrap resampling adjustment was 0.874, while the optimism-corrected Brier Score was 0.144 in internal validation. CONCLUSION: This study developed the first prediction model for PF-ILD in patients with SSc-ILD, and internal validation showed favourable accuracy and stability of the model.
引用
- Hui M, Duan X, Zhou J, et al. Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study. RMD Open. 2024. PMID: 38519110. doi:10.1136/rmdopen-2023-003715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。